Literature DB >> 3787295

Successful treatment of neuroleptic malignant syndrome with bromocriptine.

A Janati, R T Webb.   

Abstract

From our four cases, we conclude that prompt diagnosis, intensive care monitoring and support, and early use of bromocriptine can markedly reduce the duration of the symptom complex of neuroleptic malignant syndrome, as well as significantly improve the 20% mortality previously reported.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3787295     DOI: 10.1097/00007611-198612000-00022

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

Review 1.  Managing an effective treatment for neuroleptic malignant syndrome.

Authors:  Udo Reulbach; Carmen Dütsch; Teresa Biermann; Wolfgang Sperling; Norbert Thuerauf; Johannes Kornhuber; Stefan Bleich
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

2.  Neuroleptic malignant syndrome caused by a combination of carbamazepine and amitriptyline.

Authors:  A Bruce Janati; Naif Alghasab; Aboubaker Osman
Journal:  Case Rep Neurol Med       Date:  2012-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.